| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012759 |
| Receipt No. | R000014908 |
| Official scientific title of the study | The influence of oral carbohydrate loading on glucose and lipid metabolism in type 2 diabetes patients |
| Date of disclosure of the study information | 2014/01/06 |
| Last modified on | 2018/06/11 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | The influence of oral carbohydrate loading on glucose and lipid metabolism in type 2 diabetes patients | |
| Title of the study (Brief title) | The influence of oral carbohydrate loading on glucose and lipid metabolism in type 2 diabetes patients | |
| Region |
|
|
| Condition | ||
| Condition | type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to investigate the influence of oral carbohydrate loading adopted for preoperative oral rehydration therapy on glucose and lipid metabolism in type 2 diabetes patients. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Primary outcome is blood glucose level. Especially, it will compare the fluctuation of blood glucose level loading oral carbohydrate beverage with its loading water. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 10 inpatients who are treated with insulin for type 2 diabetes or 5 inpatients without diabetes.
All patients will drink water (1st day), OS-1 (2nd day) and Arginaid Water (3rd day). |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inpatients treated with insulin for type 2 diabetes whom glycemic control are stable (fasted blood glucose level is less than 150 mg/dL, and postpradial blood glucose level is less than 250 mg/dL). | |||
| Key exclusion criteria | Type 1 diabetes
Patients treated with steroid Patients whom fasted blood glucose level is more than 150 mg/dL Patients whom postpradial blood glucose level is more than 250 mg/dL Patients who have severe autonomic failure Patients who were admitted with diabetic ketoacidosis, hyperosmolar hyperglycemic nonketotic coma or lactic acidosis Patients treated with continuous injection Patients who have appetite loss or are unable to eat orally |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Eiichi Araki |
| Organization | Faculty of Life Sciences, Kumamoto University |
| Division name | Department of Metabolic Medicine |
| Address | 1-1-1 Honjo, Kumamoto, Japan |
| TEL | 096-373-5169 |
| earaki@gpo.kumamoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Junji Kawashima |
| Organization | Faculty of Life Sciences, Kumamoto University |
| Division name | Department of Metabolic Medicine |
| Address | 1-1-1 Honjo, Kumamoto, Japan |
| TEL | 096-373-5169 |
| Homepage URL | |
| junjikawa@mac.com | |
| Sponsor | |
| Institute | Department of Metabolic Medicine, Kumamoto University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otsuka Phamaceutical Factory, Inc |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 熊本大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014908 |